CGEM vs FOX · $830.3M cap vs P/E 13, rev $16.30B
Cullinan Oncology LLC (CGEM) versus Fox Corp Class B (FOX) — a side-by-side from cached financials, not a winner call.
Cullinan Oncology LLC (CGEM) is a biotechnology company listed on US.
Fox Corp Class B (FOX) is a entertainment company listed on US.
Latest reported CGEM revenue for 2022-12-31 was $0. Net income was $109.2M. CGEM currently screens at market cap $830.3M.
Latest reported FOX revenue for 2025-06-30 was $16.30B. Net income was $2.29B. Revenue was up 16.6% from 2024-06-30 to 2025-06-30. FOX currently screens at market cap $24.49B and trailing P/E 13.0.
CGEM currently screens at market cap $830.3M. FOX currently screens at market cap $24.49B and trailing P/E 13.0.
Not investment advice. Open the CGEM and FOX stock pages for the full models.
Not investment advice.